Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Viking Therapeutics, Inc. Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $94.9 Billion
- Q3 2024
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 6,356 shares of VKTX stock, worth $327,524. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,356
Previous 13,506
52.94%
Holding current value
$327,524
Previous $715,000
43.78%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
473Shares Held
66.2MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$524 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$311 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$241 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$109 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$96.6 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.95B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...